GET THE APP

Synthesis and biological screening of new 4-substit uted-2-(3,4,5- trimethoxyphenyl)quinazolines as potential anticanc er agents | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Synthesis and biological screening of new 4-substit uted-2-(3,4,5- trimethoxyphenyl)quinazolines as potential anticanc er agents

Author(s): Ehab M. Gedawy and Zeinab Mahmoud*

Cancer is an umbrella term including a diversity of diseases. The need for new anticancer agents is a necessity. On the other hand, quinazolines are biologically inter esting scaffold. 4-substituedamino-2-(3,4,5- trimethoxy)quinazolines were synthesized using anth ranilamide as a starting material. Thirteen novel 2 -(3,4,5- trimethoxyphenyl)quinazolines 4a-d and 5a-h were synthesized. The NCI - USA has chosen seven c ompounds namely 5a and 5c-h of the new quinazoline derivatives for the 60-cell lines screening. Compound 5c showed null growth percent towards the melanoma MDA-MB-435 cell line. The IC 50 for 5c was also investigated for both non- small cell lung cancer cell line A549 and colon can cer cell line HCT116. The results were 8.57 and 10. 10 μ M/ml respectively.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry